– Interview with Reinhard Laubenbacher, Ph.D., Professor, Virginia Bioinformatics Institute, Professor, Department of Mathematics, Virginia Tech, and Adjunct Professor, Department of Cancer Biology, Wake Forest University

Previous articleOpinion—Regulatory Planning Key for Emerging Technology Companies
Next articleNycomed’s Intranasal Fentanyl Drug Gains European Approval for Breakthrough Cancer Pain